Korro Bio, Inc.
KRRO
$6.04
$0.7614.39%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.69% | -7.10% | -7.75% | -2.97% | -22.33% |
| Total Depreciation and Amortization | 48.13% | 36.38% | 14.58% | -1.79% | -2.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.25% | -23.10% | -20.04% | 6.28% | 89.84% |
| Change in Net Operating Assets | 154.59% | 189.56% | 1,851.38% | 217.32% | 1.64% |
| Cash from Operations | 7.24% | 3.02% | 9.86% | 10.71% | -20.38% |
| Capital Expenditure | 89.58% | 51.09% | -3.99% | -128.46% | -138.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 127.08% | 113.34% | -3,727.25% | -654.97% | -543.11% |
| Cash from Investing | 121.53% | 105.64% | -755.19% | -1,204.86% | -868.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.44% | -99.17% | -55.13% | -55.13% | 61,229.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -265.03% |
| Cash from Financing | -99.42% | -99.13% | -51.31% | -63.06% | 393.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -338.88% | -286.37% | -223.98% | -186.65% | 908.33% |